Home/Filings/4/0001104659-23-122898
4//SEC Filing

WG Biotech ApS 4

Accession 0001104659-23-122898

CIK 0001722964other

Filed

Nov 30, 7:00 PM ET

Accepted

Dec 1, 5:15 PM ET

Size

5.9 KB

Accession

0001104659-23-122898

Insider Transaction Report

Form 4
Period: 2023-11-29
WG Biotech ApS
Director10% Owner
Transactions
  • Purchase

    Common Stock

    2023-11-29$5.97/sh+51,837$309,4774,425,229 total
Footnotes (1)
  • [F1]This transaction was executed in multiple trades at prices ranging from $5.82 to $6.00. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Issuer

Y-mAbs Therapeutics, Inc.

CIK 0001722964

Entity typeother
IncorporatedDenmark

Related Parties

1
  • filerCIK 0001753193

Filing Metadata

Form type
4
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 5:15 PM ET
Size
5.9 KB